Park Square has placed Sudha Parasuraman, MD, as Independent Board Director at Terray Therapeutics.
| less than a minute read
Terray Therapeutics Strengthens Leadership with Appointment of Sudha Parasuraman, MD to its Board of Directors
Terray Therapeutics, a biotechnology company accelerating drug discovery through the application of computational approaches to precisely generated chemical data at scale, today announced the appointment of Sudha Parasuraman, MD, as an Independent Director.

/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-23-14-44-49-507-6ab3e5e1470f335536fcf89c.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-22-15-19-50-498-6ab29c96af556e9074387689.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-15-18-23-35-620-6aa98d270810fd5205abd644.png)